The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
New insight into BRAF mutations in cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Self-citationMechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
Wan, P. T. C., Garnett, M. J., Roe, S. M., Lee, S., Niculescu-Duvaz, D., Good, V. M., Project, C. G., Jones, C. M., Marshall, C. J., Springer, C. J., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00215-6 · Cited by 2,808
Self-citationDistinct Sets of Genetic Alterations in Melanoma
Curtin, J. A., Fridlyand, J., Kageshita, T., Patel, H. N., Busam, K. J., Kutzner, H., Cho, K.-H., Aiba, S., Bröcker, E.-B., LeBoit, P. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050092 · Cited by 2,747
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Melanin pigmentation in mammalian skin and its hormonal regulation
Slominski, A., Tobin, D. J., Shibahara, S., & Wortsman, J. (2004) · Physiological Reviews · doi:10.1152/physrev.00044.2003 · Cited by 2,015
Molecular classification of cutaneous malignant melanoma by gene expression profiling
Bittner, M., Meltzer, P., Chen, Y., Jiang, Y., Seftor, E., Hendrix, M., Radmacher, M., Simon, R., Yakhini, Z., Ben-Dor, A., et al. (2000) · Nature · doi:10.1038/35020115 · Cited by 1,990
High frequency of BRAF mutations in nevi
Pollock, P. M., Harper, U. L., Hansen, K. S., Yudt, L. M., Stark, M., Robbins, C. M., Moses, T. Y., Hostetter, G., Wagner, U., Kakareka, J., et al. (2003) · Nature Genetics · doi:10.1038/ng1054 · Cited by 1,730
RAF/RAS oncogenes and mismatch-repair status
Rajagopalan, H., Bardelli, A., Lengauer, C., Kinzler, K. W., Vogelstein, B., & Velculescu, V. E. (2002) · Nature · doi:10.1038/418934a · Cited by 1,224
A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma
Clark, W. H., Elder, D. E., Guerry, D., Epstein, M. N., Greene, M. H., & Van Horn, M. (1984) · Human Pathology · doi:10.1016/s0046-8177(84)80310-x · Cited by 975
Cyclic AMP a Key Messenger in the Regulation of Skin Pigmentation
BUSCÀ, R., & BALLOTTI, R. (2000) · Pigment Cell Research · doi:10.1034/j.1600-0749.2000.130203.x · Cited by 806
Garnett, M. J., & Marais, R. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.022 · Cited by 799
Self-citationGermline KRAS mutations cause Noonan syndrome
Schubbert, S., Zenker, M., Rowe, S. L., Böll, S., Klein, C., Bollag, G., van der Burgt, I., Musante, L., Kalscheuer, V., Wehner, L.-E., et al. (2006) · Nature Genetics · doi:10.1038/ng1748 · Cited by 730
Germline mutations in HRAS proto-oncogene cause Costello syndrome
Aoki, Y., Niihori, T., Kawame, H., Kurosawa, K., Ohashi, H., Tanaka, Y., Filocamo, M., Kato, K., Suzuki, Y., Kure, S., et al. (2005) · Nature Genetics · doi:10.1038/ng1641 · Cited by 679
Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome
Niihori, T., Aoki, Y., Narumi, Y., Neri, G., Cavé, H., Verloes, A., Okamoto, N., Hennekam, R. C. M., Gillessen-Kaesbach, G., Wieczorek, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1749 · Cited by 599
Germline Mutations in Genes Within the MAPK Pathway Cause Cardio-facio-cutaneous Syndrome
Rodriguez-Viciana, P., Tetsu, O., Tidyman, W. E., Estep, A. L., Conger, B. A., Cruz, M. S., McCormick, F., & Rauen, K. A. (2006) · Science · doi:10.1126/science.1124642 · Cited by 571
Hoek, K. S., Schlegel, N. C., Brafford, P., Sucker, A., Ugurel, S., Kumar, R., Weber, B. L., Nathanson, K. L., Phillips, D. J., Herlyn, M., et al. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00322.x · Cited by 555
Differential Regulation of Raf-1, A-Raf, and B-Raf by Oncogenic Ras and Tyrosine Kinases
Marais, R., Light, Y., Paterson, H. F., Mason, C. S., & Marshall, C. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4378 · Cited by 456
Self-citationThe dark side of Ras: regulation of apoptosis
Cox, A. D., & Der, C. J. (2003) · Oncogene · doi:10.1038/sj.onc.1207111 · Cited by 437
The gene expression signatures of melanoma progression
Haqq, C., Nosrati, M., Sudilovsky, D., Crothers, J., Khodabakhsh, D., Pulliam, B. L., Federman, S., Miller, J. R., Allen, R. E., Singer, M. I., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501564102 · Cited by 433
B-RAF is a therapeutic target in melanoma
Karasarides, M., Chiloeches, A., Hayward, R., Niculescu-Duvaz, D., Scanlon, I., Friedlos, F., Ogilvie, L., Hedley, D., Martin, J., Marshall, C. J., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207785 · Cited by 426
Self-citationSatyamoorthy, K., Li, G., Gerrero, M. R., Brose, M. S., Volpe, P., Weber, B. L., Belle, P. A. V., Elder, D. E., & Herlyn, M. (2003) · PubMed · Cited by 426
Regulation and Role of Raf-1/B-Raf Heterodimerization
Rushworth, L. K., Hindley, A. D., O'Neill, E., & Kolch, W. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2262-2272.2006 · Cited by 418
Wild-Type and Mutant B-RAF Activate C-RAF through Distinct Mechanisms Involving Heterodimerization
Garnett, M. J., Rana, S., Paterson, H., Barford, D., & Marais, R. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.022 · Cited by 416
Self-citationSuppression of BRAF(V599E) in human melanoma abrogates transformation.
Hingorani, S. R., Jacobetz, M. A., Robertson, G. P., Herlyn, M., & Tuveson, D. A. (2003) · PubMed · Cited by 408
Yuen, S. T., Davies, H. R., Chan, T. L., Ho, J. W. C., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Tsui, W. W., Chan, A. S. Y., et al. (2002) · PubMed · Cited by 404
Cellular senescence in naevi and immortalisation in melanoma: a role for p16?
Gray-Schopfer, V. C., Cheong, S. C., Chong, H., Chow, J., Moss, T., Abdel-Malek, Z. A., Marais, R., Wynford-Thomas, D., & Bennett, D. C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603283 · Cited by 394
Self-citationTopical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning
D'Orazio, J. A., Nobuhisa, T., Cui, R., Arya, M., Spry, M., Wakamatsu, K., Igras, V., Kunisada, T., Granter, S. R., Nishimura, E. K., et al. (2006) · Nature · doi:10.1038/nature05098 · Cited by 350
MC1R Germline Variants Confer Risk for BRAF -Mutant Melanoma
Landi, M. T., Bauer, J., Pfeiffer, R. M., Elder, D. E., Hulley, B., Minghetti, P., Calista, D., Kanetsky, P. A., Pinkel, D., & Bastian, B. C. (2006) · Science · doi:10.1126/science.1127515 · Cited by 346
V599EB-RAF is an Oncogene in Melanocytes
Wellbrock, C., Ogilvie, L., Hedley, D., Karasarides, M., Martin, J., Niculescu-Duvaz, D., Springer, C. J., & Marais, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3433 · Cited by 344
Self-citationRole of the Kinase MST2 in Suppression of Apoptosis by the Proto-Oncogene Product Raf-1
O'Neill, E., Rushworth, L., Baccarini, M., & Kolch, W. (2004) · Science · doi:10.1126/science.1103233 · Cited by 317
Chen, J., Fujii, K., Zhang, L., Roberts, T., & Fu, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141224398 · Cited by 316
Active Ras induces heterodimerization of cRaf and BRaf.
Weber, C., Slupsky, J. R., Kalmes, H. A., & Rapp, U. R. (2001) · PubMed · Cited by 312
Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene
Mikula, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.8.1952 · Cited by 311
MEK kinase activity is not necessary for Raf-1 function
Huser, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.8.1940 · Cited by 310
BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.
Dong, J., Phelps, R. G., Qiao, R., Yao, S., Benard, O., Ronai, Z. A., & Aaronson, S. A. (2003) · PubMed · Cited by 310
The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma
Valverde, P. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.10.1663 · Cited by 304
Dumaz, N., Hayward, R., Martin, J., Ogilvie, L., Hedley, D., Curtin, J. A., Bastian, B. C., Springer, C., & Marais, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4227 · Cited by 304
Self-citationEndothelial apoptosis in Braf-deficient mice
Wojnowski, L., Zimmer, A. M., Beck, T. W., Hahn, H., Bernal, R., Rapp, U. R., & Zimmer, A. (1997) · Nature Genetics · doi:10.1038/ng0797-293 · Cited by 299
Houben, R., Becker, J. C., Kappel, A., Terheyden, P. A. M., Bröcker, E., Goetz, R., & Rapp, U. R. (2004) · Journal of Carcinogenesis · doi:10.1186/1477-3163-3-6 · Cited by 294
Oncogenic BRAF Is Required for Tumor Growth and Maintenance in Melanoma Models
Hoeflich, K. P., Gray, D. C., Eby, M. T., Tien, J. Y., Wong, L., Bower, J., Gogineni, A., Zha, J., Cole, M. J., Stern, H. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2720 · Cited by 232
Pritchard, C. A., Samuels, M. L., Bosch, E., & McMahon, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.11.6430 · Cited by 224
Mutations of the BRAF Gene in Benign and Malignant Melanocytic Lesions
Yazdi, A. S., Palmedo, G., Flaig, M. J., Puchta, U., Reckwerth, A., Rütten, A., Mentzel, T., Hügel, H., Hantschke, M., Schmid-Wendtner, M.-H., et al. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12559.x · Cited by 221
Death receptors and melanoma resistance to apoptosis
Ivanov, V. N., Bhoumik, A., & Ronai, Z. (2003) · Oncogene · doi:10.1038/sj.onc.1206456 · Cited by 211
BRAF alterations are associated with complex mutational profiles in malignant melanoma
Daniotti, M., Oggionni, M., Ranzani, T., Vallacchi, V., Campi, V., Di Stasi, D., Torre, G. D., Perrone, F., Luoni, C., Suardi, S., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207780 · Cited by 210
Emuss, V., Garnett, M., Mason, C., The Cancer Genome Project, & Marais, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1683 · Cited by 207
Self-citationRaf-1 regulates Rho signaling and cell migration
Ehrenreiter, K., Piazzolla, D., Velamoor, V., Sobczak, I., Small, J. V., Takeda, J., Leung, T., & Baccarini, M. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200409162 · Cited by 207
BRAF mutations in metastatic melanoma: a possible association with clinical outcome.
Kumar, R., Angelini, S., Czene, K., Sauroja, I., Hahka‐Kemppinen, M., Pyrhönen, S. O., & Hemminki, K. (2003) · PubMed · Cited by 205
Microarray expression profiling in melanoma reveals a BRAF mutation signature
Pavey, S., Johansson, P., Packer, L., Taylor, J., Stark, M., Pollock, P. M., Walker, G. J., Boyle, G. M., Harper, U., Cozzi, S.-J., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207563 · Cited by 183
Mercer, K., Giblett, S., Green, S., Lloyd, D., DaRocha Dias, S., Plumb, M., Marais, R., & Pritchard, C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2211 · Cited by 179
Self-citationMC1R and the response of melanocytes to ultraviolet radiation
Rouzaud, F., Kadekaro, A. L., Abdel-Malek, Z. A., & Hearing, V. J. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.09.014 · Cited by 173
Molecular determinants of human uveal melanoma invasion and metastasis
Seftor, E. A., Meltzer, P. S., Kirschmann, D. A., Pe'er, J., Maniotis, A. J., Trent, J. M., Folberg, R., & Hendrix, M. J. C. (2002) · Clinical & Experimental Metastasis · doi:10.1023/a:1015591624171 · Cited by 165
Ikenoue, T., Hikiba, Y., Kanai, F., Tanaka, Y., Imamura, J., Imamura, T., Ohta, M., Ijichi, H., Tateishi, K., Kawakami, T., et al. (2003) · PubMed · Cited by 164
Gray‐Schopfer, V. C., Dias, S. D. R., & Marais, R. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-5865-1 · Cited by 160
Self-citationTumor Necrosis Factor-α Blocks Apoptosis in Melanoma Cells when BRAF Signaling Is Inhibited
Gray‐Schopfer, V. C., Karasarides, M., Hayward, R., & Marais, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1880 · Cited by 135
Self-citationEffect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines
Bloethner, S., Chen, B., Hemminki, K., Müller‐Berghaus, J., Ugurel, S., Schadendorf, D., & Kumar, R. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi066 · Cited by 135
Melanocortin 1 receptor variants and skin cancer risk
Han, J., Kraft, P. L., Colditz, G. A., Wong, J. Y. Y., & Hunter, D. J. (2006) · International Journal of Cancer · doi:10.1002/ijc.22074 · Cited by 123
Craf-1 protein kinase is essential for mouse development
Wojnowski, L., Stancato, L. F., Zimmer, A. M., Hahn, H., Beck, T. W., Larner, A. C., Rapp, U. R., & Zimmer, A. (1998) · Mechanisms of Development · doi:10.1016/s0925-4773(98)00111-7 · Cited by 121
d’Ischia, M., Napolitano, A., & Prota, G. (1991) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(91)90152-7 · Cited by 116
Population-Based Study of Natural Variation in the Melanocortin-1 Receptor Gene and Melanoma
Kanetsky, P. A., Rebbeck, T. R., Hummer, A., Panossian, S., Armstrong, B. K., Kricker, A., Marrett, L. D., Millikan, R. C., Gruber, S. B., Culver, H. A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1634 · Cited by 114
Essential role of B-Raf in ERK activation during extraembryonic development
Galabova‐Kovacs, G., Matzen, D., Piazzolla, D., Meissl, K., Plyushch, T., Chen, A. P., Silva, A. J., & Baccarini, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507399103 · Cited by 113
Stratigos, A., Dimisianos, G., Nikolaou, V. A., Poulou, M., Sypsa, V., Stefanaki, I., Papadopoulos, O. N., Polydorou, D., Plaka, M., Christofidou, E., et al. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700292 · Cited by 100
Chadee, D. N., Xu, D., Hung, G., Andalibi, A., LIM, D. J., Luo, Z., Gutmann, D. H., & Kyriakis, J. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510651103 · Cited by 97
Zebisch, A., Staber, P. B., Delavar, A., Bodner, C., Hiden, K., Fischereder, K., Janakiraman, M., Linkesch, W., Auner, H. W., Emberger, W., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-0115 · Cited by 90
Nappi, A. J., & Vass, E. (1996) · Melanoma Research · doi:10.1097/00008390-199610000-00001 · Cited by 81
Ikenoue, T., Hikiba, Y., Kanai, F., Aragaki, J., Tanaka, Y., Imamura, J., Imamura, T., Ohta, M., Ijichi, H., Tateishi, K., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3591 · Cited by 77
Fargnoli, M. C., Altobelli, E., Keller, G., Chimenti, S., Höfler, H., & Peris, K. (2006) · Melanoma Research · doi:10.1097/01.cmr.0000198454.11580.b5 · Cited by 47
Mutational analysis of the ARAF gene in human cancers
Lee, J. W., Soung, Y. H., Kim, S. Y., Park, W. S., Nam, S. W., Min, W. S., Kim, S. H., Lee, J. Y., Yoo, N. J., & Lee, S. H. (2005) · Apmis · doi:10.1111/j.1600-0463.2005.apm1130108.x · Cited by 47
B-Raf and Ha-ras mutations in chemically induced mouse liver tumors
Jaworski, M., Buchmann, A., Bauer, P. O., Rieß, O., & Schwarz, M. (2004) · Oncogene · doi:10.1038/sj.onc.1208265 · Cited by 43
Mößner, R., Anders, N., König, I. R., Krüger, U., Schmidt, D., Berking, C., Ziegler, A., Brockmöller, J., Kaiser, R., Volkenandt, M., et al. (2006) · Archives of Dermatological Research · doi:10.1007/s00403-006-0708-7 · Cited by 42
MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk
Dębniak, T., Scott, R. J., Masojć, B., Serrano‐Fernández, P., Huzarski, T., Byrski, T., Dębniak, B., Górski, B., Cybulski, C., Mędrek, K., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22210 · Cited by 41
Rapp, U. R., Rennefahrt, U. E. E., & Troppmair, J. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.10.015 · Cited by 27
Absence of BRAF Gene Mutation in Non-Melanoma Skin Tumors
Libra, M., Malaponte, G., Bevelacqua, V., Siciliano, R., Castrogiovanni, P., Fulvi, A., Micali, G., Ligresti, G., Mazzarino, M. C., Stivala, F., et al. (2006) · Cell Cycle · doi:10.4161/cc.5.9.2724 · Cited by 21
BRAF and MEK Mutations Make a Late Entrance
Duesbery, N. S., & Woude, G. V. (2006) · Science s STKE · doi:10.1126/stke.3282006pe15 · Cited by 14
Cited by
Xing, M. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0007 · Cited by 983
Wajapeyee, N., Serra, R. W., Zhu, X., Mahalingam, M., & Green, M. R. (2008) · Cell · doi:10.1016/j.cell.2007.12.032 · Cited by 903
Ras in Cancer and Developmental Diseases
Fernandez-Medarde, A., & Santos, E. (2011) · Genes & Cancer · doi:10.1177/1947601911411084 · Cited by 897
Venderbosch, S., Nagtegaal, I. D., Maughan, T. S., Smith, C. G., Cheadle, J. P., Fisher, D., Kaplan, R., Quirke, P., Seymour, M. T., Richman, S. D., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0332 · Cited by 772
Regulation and function of the RSK family of protein kinases
Romeo, Y., Zhang, X., & Roux, P. P. (2012) · Biochemical Journal · doi:10.1042/bj20110289 · Cited by 377
Metadata
- Authors
- Dhomen, N., & Marais, R.
- Venue
- Current Opinion in Genetics & Development
- Publisher
- Elsevier BV
- Published
- 2007-02
- Volume
- 17
- Issue
- 1
- Pages
- 31-39
- ISSN
- 0959-437X (ISSN-L)
- OpenAlex
- W2126731289
- Cited by
- 278
- References
- 73
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.